Cyproheptadine Hydrochloride
NDC 52817-415, Cyproheptadine Hydrochloride, tablet, from TRUPHARMA, LLC.
- Product NDC
- 52817-415
- Status
- Listed
- Labeler
- TRUPHARMA, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206553
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52817-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYPROHEPTADINE HYDROCHLORIDE4 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52817-415-10 | 52817041510 | 100 TABLET in 1 BOTTLE, PLASTIC (52817-415-10) |
| 52817-415-50 | 52817041550 | 500 TABLET in 1 BOTTLE, PLASTIC (52817-415-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1d668d93-8c9e-479e-ad8d-59656c8dec1b
Use it
Look up 52817-415 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52817-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52817-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.